The FDA will ask Sarep­ta to stop ship­ping its Duchenne mus­cu­lar dy­s­tro­phy treat­ment Ele­v­idys, an HHS of­fi­cial said, in what could be a fi­nal blow to the com­pa­ny's hopes for the prod­uct fol­low­ing two pa­tients' deaths...